Cellceutix Corp. Reports Favorable Results on Trial of New Antibiotic

The solid showing comes less than two weeks after the Beverly, Mass.-based pharmaceutical company reported favorable results in a recently completed preclinical study evaluating its new antibiotic compounds against specific strains of multi-drug resistant Klebsiella pneumoniae.

http://ift.tt/1hJwl3D